Comparison of efficacy and safety of biphasic insulin aspart [insulin aspart/insulin protamine aspart] plus metformin to biphasic insulin aspart monotherapy in subjects with type 2 diabetes
Phase of Trial: Phase IV
Latest Information Update: 09 Jan 2017
At a glance
- Drugs Insulin aspart/insulin protamine aspart; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 15 May 2009 Actual patient number (140) added as reported by ClinicalTrials.gov.
- 15 May 2009 Actual end date (May 2005) added as reported by ClinicalTrials.gov.